Great news for the Medical Device industry! The Government has just issued Decree No. 26/2026/ND-CP, and it’s a game-changer for how we manage chemicals in healthcare.
For years, the MedTech sector has navigated complex, overlapping regulations. This new Decree brings much-needed clarity and efficiency by confirming that the Ministry of Health (MOH) is the sole responsible authority for chemicals used in: ✅ Medical Devices ✅ In Vitro Diagnostics (IVDs) ✅ Medicinal Products ✅ Other MOH-regulated goods
Why is this a big deal for our industry?
1️⃣ Goodbye Regulatory Overlap: No more juggling conflicting requirements between the Ministry of Industry and Trade (MOIT) and the MOH. One authority means one set of rules.
2️⃣ Faster Market Access: By removing duplicative approval layers, we can expect reduced lead times for importing and distributing essential medical technologies.
3️⃣ Supply Chain Certainty: Policy clarity directly translates to lower risk for manufacturers and distributors, ensuring that life-saving products reach patients without unnecessary bureaucratic delays.
4️⃣ Cost Efficiency: Streamlined compliance procedures mean lower administrative costs, allowing companies to focus resources on innovation and patient care.
This is a landmark advocacy outcome that protects continued access to essential medical technologies while strengthening Vietnam’s regulatory framework.
A big step forward for the “Ease of Doing Business” in Vietnam’s healthcare sector🏥